Skip to main content

Table 1 Frequencies of clinical and tumor biological factors

From: The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients

Age group

30-40years

34/100

41-50years

66/100

Tumor size (pathologic)

T1

64/100

T2

36/100

Lymph node involvement (pathologic)

N0

55/100

N1

45/100

Grade

 

G1

9/100

G2

62/100

G3

29/100

Estrogen receptors (ER)

ER positive

57/100

ER negative

43/100

Progestin receptors (PR)

PR positive

48/100

PR negative

52/100

Human epidermal growth factor receptor 2 (HER2)

HER2 positive

28/100

HER2 negative

72/100

Intrinsic subtype

Luminal A

46/100

Luminal B

18/100

HER2 enriched

10/100

‘Basal-like’

26/100